Click here for printer friendly page
Weekly People Roundup: 7 September 200507/09/2005. Source: AltAssets. 
 All the week's most important people stories from across the globe. Essential reading for those who need to keep up-to-date with the private equity industry's key staff moves.
Transatlantic venture capital firm Logispring has appointed Burt Hurlock as the firm's first US-based partner. Hurlock will work out of Boston, Massachusetts. He has been a venture capital investor and entrepreneur for 15 years during which he formed three companies that completed more than 30 acquisitions.
New Zealand venture investment firm Pioneer Capital Partners has appointed life sciences veteran Dr David Evans to its New Zealand Innovation Fund advisory board. Pioneer's recently-launched NZ Innovation Fund is an investment programme established to capitalise on the rich flow of venture investment opportunities originating in New Zealand that are ripe for growth in international markets.
European mid-market private equity investor HgCapital has appointed Alex King to its technology investment team as it expands its business in Germany and in the Benelux region. King was previously a director at Kennet Venture Partners and, prior to that, a consultant with Spectrum Strategy Consultants. HgCapital, founded in 2000 as the successor to Mercury Private Equity, invests in the consumer, healthcare, industrials, leisure, media and technology sectors. The firm has funds under management of €1.4bn.
3i has appointed Frederik Roth as senior director. He will join 3i's European buy-out team and will be based in Frankfurt. Roth will report directly to Dr Stephan Krümmer, managing director of 3i Germany. Roth joins 3i from Permira, where he has spent over nine years in their Frankfurt office. He has been involved in several Continental European acquisitions including Austriamicrosystems, Leica Microsystems, Single Temperiertechnik and Hofmann Menü. Roth began his career in the high tech and automotive industry at Balzers. He has also held management responsibilities in the engineering and automotive sector with ABB and Aeroquip. 3i focuses on buy-outs, growth capital and venture capital and invest across Europe, in the United States and in Asia.
InnovationsKapital, a start-up and early-stage venture capitalist operating in the Nordic region, has hired Ulf Tossman as a new investment director in the Healthcare & Life Sciences team. Tossman joins InnovationsKapital from Carnegie Asset Management, where he held the position of senior portfolio manager, managing a global life science fund. Prior to that he was executive vice president, global R&D at Fresenius Kabi. He also gained experience in drug development and the commercialisation process as medical director of Schering Northern Europe and as project director of CNS products at Astra Arcus.
GSC Partners, the transatlantic mezzanine and debt specialist, has appointed former Goldman Sachs partner Joseph H Wender as a managing director. Wender will work closely with Alfred C Eckert III, chairman and chief executive officer, and the other senior officers of the firm to explore new investment opportunities and expand geographically, GSC Partners said. Wender will oversee the firm's new Los Angeles.
The office has been opened to serve as a platform to establish a broader presence in the region. Wender spent more than 30 years at Goldman Sachs. He joined the company in 1971 and became a general partner in 1982, where he headed the Financial Institutions Group for over a decade. During his tenure with Goldman Sachs, Wender specialised in mergers and banking industry transactions and was instrumental in the mergers of BankAmerica with Nations, Wells Fargo with Norwest, and Chase with Chemical.
Copyright © 2005 AltAssets
|
